We focused our validation experiments on three major kinases involved in cancer: the tyrosine kinase ABL1, the mitogen‐activated protein kinase (MAPK) member ERK2, and one of the four p38 MAPKs, MAPK14. The gene discussed is MAPK1; the disease is cancer.